Skip to main content

Stoke Therapeutics, Inc.

STOK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001623526

In the last 90 days, Stoke Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 197 institutions reported holding it in 13F filings for Q2 2026, worth $2.49B in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Stoke Therapeutics, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of STOK: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders9094+4
Shares19.4M35.4M+16.1M (+83.1%)
Value$492.4M$849.6M+$357.2M (+72.5%)

New holders (20)

Institutions that held Stoke Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to STOK in Q4 2021
InstitutionSharesValue% of portfolio
Skorpios Trust14,443,681$346.5M76.67%
M28 Capital Management LP527,150$12.6M9.87%
Point72 Asset Management, L.P.233,997$5.61M0.02%
Ally Bridge Group (NY) LLC185,000$4.44M1.55%
Fort Point Capital Partners LLC160,000$3.84M0.54%
Marshall Wace, LLP42,401$1.02M0.00%
Trexquant Investment LP26,399$633.0K0.04%
Jacobs Levy Equity Management, Inc22,480$539.0K0.00%
Tudor Investment Corp Et Al19,477$467.0K0.01%
HRT Financial LP18,057$433.0K0.00%
Russell Investments Group, Ltd.13,313$319.0K0.00%
D. E. Shaw & Co., Inc.10,065$241.0K0.00%
Connor, Clark & Lunn Investment Management Ltd.9,395$225.0K0.00%
Aquatic Capital Management LLC1,300$31.0K0.06%
Northwestern Mutual Wealth Management Co750$18.0K0.00%
US Bancorp121$3.00K0.00%
HM Payson & Co99$2.00K0.00%
Beaird Harris Wealth Management, LLC76$2.00K0.00%
CWM, LLC55$1.00K0.00%
Westwood Wealth Management95––

Sold out (16)

Institutions that held Stoke Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.